Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population.

Thang SP, Lam WWC, Tong AKT, Allen JC, Ler ASL, Tay YS, Somanesan S, Kanesvaran R, Wong ASC, Ng DCE. Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population. Nucl Med Commun. 2020 Jul; 41(7):618-628.

View in: PubMed

subject areas

Adult
Aged
Humans
Kallikreins
Lutetium
Male
Middle Aged
Pain
Pilot Projects
Prospective Studies
Prostate-Specific Antigen
Prostatic Neoplasms
Radioisotopes
Survival Analysis
Treatment Outcome

authors with profiles

John S. Allen, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support